Tin Protoporphyrin Activates the Oxidant Dependent NRF2 – Cytoprotective Pathway and Mitigates Acute Kidney Injury

Abstract Tin protoporphyrin (SnPP), a heme oxygenase (HO) inhibitor, can paradoxically protect against diverse forms of AKI. This study sought potential underlying mechanisms. CD-1 mice received IV SnPP, followed 4-18 hrs later by a variety of renal biochemical, histologic, and genomic assessments....

Full description

Saved in:
Bibliographic Details
Published inTranslational research : the journal of laboratory and clinical medicine Vol. 186; pp. 1 - 18
Main Authors Johnson, Ali CM., BS, Delrow, Jeff J., PhD, Zager, Richard A., MD
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.08.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Tin protoporphyrin (SnPP), a heme oxygenase (HO) inhibitor, can paradoxically protect against diverse forms of AKI. This study sought potential underlying mechanisms. CD-1 mice received IV SnPP, followed 4-18 hrs later by a variety of renal biochemical, histologic, and genomic assessments. Renal resistance to ischemic-reperfusion injury (IRI) was also sought. SnPP was rapidly taken up by kidney, and was confined to proximal tubules. Transient suppression of renal heme synthesis (decreased δ aminolevulinic acid synthase expression), a 2.5 fold increase in “catalytic” Fe levels, and oxidant stress resulted (decreased glutathione; increased malondialdehyde and protein carbonyl content). Nrf2 nuclear translocation (∼2x Nrf2 increase; detected by ELISA, Western blotting), with corresponding activation of ∼20 Nrf2-sensitive genes (RNA-Seq) were observed. By 18 hrs post-SnPP injection, marked protection against IRI emerged. This represented “preconditioning”, not a direct SnPP effect, given that SnPP administered at the time of IRI exerted no protective effect. The importance of transient oxidant stress in SnPP “preconditioning” was exemplified by the following: i) oxidant stress induced by a different mechanism (myoglobin injection) recapitulated SnPP’s protective action; ii) GSH treatment blunted SnPP’s protective influence; iii) SnPP raised cytoprotective heavy chain ferritin (Fhc), a response enhanced by exogenous Fe injection; and iv) SnCl2 , a ∼35-50 fold HO-1 inducer (not inhibitor) evoked neither oxidant stress nor mitigated IRI (seemingly excluding HO-1 activity in SnPP’s protective effect). Conclusions: 1) SnPP specifically accumulates within proximal tubule cells; transient “catalytic” Fe overload and oxidative stress result; Nrf2-cytoprotective pathways are up-regulated; and these changes help protect against ischemic AKI.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1931-5244
1878-1810
DOI:10.1016/j.trsl.2017.05.005